LED Medical Diagnostics Inc. announced earnings results for the three months and nine months ended September 30, 2018. For the three months, the company reported revenue of $3,400,904, this includes $61,761 of sales delivered in Quarter 1 and $92,642 of sales delivered in Quarter 2 of fiscal 2018, invoiced in the Quarter 3 period. This represents an increase of 6% from the three months ended September 30, 2017. EBITDA for the three months ended September 30, 2018 was $385,624 from a loss of $58,673 in the three months ended September 30, 2017. Net loss was $176,507 for the three months ended September 30, 2018 compared to net loss of $1,447,713 for the three months ended September 30, 2017. For the nine months, the company reported revenue of $10,404,183 against $8,994,878 a year ago. EBITDA for the nine months ended September 30, 2018 was $513,775 representing an increase from negative EBITDA of $782,604 in the prior year period. Net income for the nine months ended September 30, 2018 was $278,317 representing a significant improvement from a net loss of $1,630,441 in the prior year period.